NSF's Ambitious Plans Outpace Budget Hikes

David Sanchez presides over a $600 million budget as assistant National Science Foundation director for the mathematical and physical sciences. But even with steady growth each year in that budget, he says he's hard-pressed to find the money next year to continue work on, among other projects, a $211 million laser interferometer gravity wave observatory (LIGO), a $192 million eight-meter telescope, and a $120 million high magnetic field laboratory. "If we put in much less than what the proje

Written byJeffrey Mervis
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

"If we put in much less than what the project really needs, then all we're really doing is stretching out its eventual cost," he says. "And that makes it vulnerable to an even bigger hit down the road. By slowing down the funding, you're also hurting the science. But with future budgets likely to increase by no more than 5 percent or so, these projects are really imposing some heavy mortgages on us."

Not all projects can be stretched to accommodate budgetary constraints, Sanchez points out. "Take the magnet lab [being built in Florida]. They're at the top of their request right now; they have to put up a building and build the magnets. And they're making phenomenal progress. A site visit team just came back with a glowing report. Given all of that, I'd hate to have to tell them that we're cutting their budget."

One of the biggest ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies